Clin Endocrinol Metab. 1998 Apr; 83(4):1049-55. 38. McDonagh AJ, Tazi-Ahnini R.Epidemiology and genetics of alopecia areata.39. Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med. 1993 Nov-Dec; 66(6):541-54. 40. Paus R. Immunology of the hair follicle. In: Bos JD, ed. Skin immune system (SIS) Cutaneous immunology and clinical immunodermatology, 2nd edition. Boca Ranton: CRC press, 1997: 377-398. 41. Price VH, Khoury EL. Alopecia areata. Prog Dermatol 1991; 25:1-7. 42. Goldsmith LA. Summary of alopecia areata research workshop and future research directions. J Invest Dermatol 1991; 96: 98s?100s. 43. Kern F, Hoffman WH, Hambrick GW Jr, Blizzard RM. Alopecia areata. Immunologic studies and treatment with prednisone. Arch Dermatol. 1973 Mar; 107(3):407-12.44. Korkij W, Soltani K, Simjee S, Marcincin PG, Chuang TY. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study. J Cutan Pathol. 1984 Dec; 11(6):522-30.45. Friedmann PS. Response of alopecia areata to DNCB: influence of auto-antibodies and route of sensitization. Br J Dermatol. 1981 Sep; 105(3):285-9. 46. Galbraith GM, Thiers BH, Pandey JP. Gm allotype associated resistance and susceptibility to alopecia areata.Clin Exp Immunol. 1984 Apr; 56(1):149-52.47. Zauli D, Veronesi S, Fusconi M, Lama L, Melino M, Tosti A, Bianchi FB. autoantibodies in alopecia areata. Br J Dermatol. 1984 Aug; 111(2):247.48. Betterle C, Greggio NA, Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998 Apr; 83(4):1049-55. 49. Cochran RE, Thomson J, MacSween RN. An auto-antibody profile in alopecia totalis and diffuse alopecia. Br J Dermatol. 1976 Jul; 95(1):61-5.50. Muller HK, Rook AJ, Kubba R. Immunohistology and autoantibody studies in alopecia areata. Br J Dermatol. 1980 May; 102(5):609-10.51. Nunzi E, Hamerlinck F, Cormane RH. Immunopathological studies on alopecia areata. Arch Dermatol Res. 1980; 269(1):1-11.52. Werth VP, White WL, Sanchez MR, Franks AG. Incidence of alopecia areata in lupus erythematosus. Arch Dermatol 1992; 128(3): 368-371.53. Tan RS. Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc R Soc Med. 1974 Mar; 67(3):195-6.54. Kern F, Hoffman WH, Hambrick GW Jr, Blizzard RM. Alopecia areata. Immunologic studies and treatment with prednisone. Arch Dermatol. 1973 Mar; 107(3):407-12. 55. Klaber MR, Munro DD. Alopecia areata: immunofluorescence and other studies.Br J Dermatol. 1978 Oct; 99(4):383-6.56. Igarashi R, Takeuchi S, Sato Y. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata. Acta Derm Venereol. 1980; 60(1):33-7.57. Tobin DJ, Hann SK, Song MS, Bystryn JC. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol. 1997 Jan; 133(1):57-61.58. Tobin DJ, Orentreich N, Fenton DA, Bystryn JC. Antibodies to hair follicles in alopecia areata. J Invest Dermatol. 1994 May; 102(5):721-4.59. McElwee KJ, Pickett P, Oliver RF. The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 1996 Jan; 134(1):55-63.60. Tobin DJ, Bystryn JC. Immunity to hair follicles in alopecia areata. J Invest Dermatol. 1995 May; 104(5 Suppl): 13S-14S.61. Walker SA, Rothman S. Alopecia areata: a statistical study and consideration of endocrines influences.